In December 2025, Castle Biosciences reported Nature Communications data from the largest prospective, multicenter uveal melanoma study showing that combining its DecisionDx-UM test with PRAME gene ...
Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...
The Merlin CP-GEP Test, validated in the largest prospective gene expression profiling study in melanoma ( MERLIN_001 ), demonstrated that a High-Risk result identifies patients with a threefold ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback